AU5811600A - Vaccine - Google Patents

Vaccine

Info

Publication number
AU5811600A
AU5811600A AU58116/00A AU5811600A AU5811600A AU 5811600 A AU5811600 A AU 5811600A AU 58116/00 A AU58116/00 A AU 58116/00A AU 5811600 A AU5811600 A AU 5811600A AU 5811600 A AU5811600 A AU 5811600A
Authority
AU
Australia
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58116/00A
Inventor
Jean-Paul Prieels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU5811600A publication Critical patent/AU5811600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/5555Muramyl dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP
AU58116/00A 1999-06-08 2000-06-06 Vaccine Abandoned AU5811600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9913327.4A GB9913327D0 (en) 1999-06-08 1999-06-08 Vaccine
GB9913327 1999-06-08
PCT/EP2000/005164 WO2000074716A2 (en) 1999-06-08 2000-06-06 Ige peptides for allergy immunotherapy

Publications (1)

Publication Number Publication Date
AU5811600A true AU5811600A (en) 2000-12-28

Family

ID=10854961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58116/00A Abandoned AU5811600A (en) 1999-06-08 2000-06-06 Vaccine

Country Status (3)

Country Link
AU (1) AU5811600A (en)
GB (1) GB9913327D0 (en)
WO (1) WO2000074716A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
EP1718669A4 (en) * 2004-02-02 2007-10-10 Tanox Inc Identification of novel ige epitopes
EP1930729A1 (en) * 2006-12-04 2008-06-11 Medizinische Universität Wien Method for in vivo and in vitro testing for a pharmaceutical drug induced immediate type hypersensitivity reactions
US9920100B2 (en) 2015-06-05 2018-03-20 The Chinese University Of Hong Kong Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1578348A (en) * 1976-08-17 1980-11-05 Pharmacia Ab Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic
JPH09510975A (en) * 1994-03-28 1997-11-04 ユナイテッド・バイオメディカル・インコーポレイテッド Synthetic peptide-based immunogen for the treatment of allergies
AU2672700A (en) * 1999-02-25 2000-09-14 Peptide Therapeutics Limited Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses

Also Published As

Publication number Publication date
WO2000074716A3 (en) 2001-07-19
WO2000074716A2 (en) 2000-12-14
GB9913327D0 (en) 1999-08-11

Similar Documents

Publication Publication Date Title
IL145043A0 (en) Vaccine
AU1173201A (en) Skin-gripper
HUS1300072I1 (en) Vaccine
AU5977700A (en) Vaccines
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU1600401A (en) Malaria vaccine
AU6158700A (en) Vaccine
AU5811600A (en) Vaccine
GB9906437D0 (en) Vaccine
AU1901801A (en) Glucofuranoses
AU1915601A (en) Periotome
AU5084300A (en) New vaccine formulations - 1
AU1101701A (en) Vaccine compositions
AU2197301A (en) Microlamp
AU4935700A (en) New vaccine formulations-3
AU2153801A (en) Idiotype vaccines
AU1737601A (en) Collectalbum
GB9909072D0 (en) Vaccine
AU2001285773A1 (en) Vaccine
AUPQ245999A0 (en) Vaccine strategy
GB9904408D0 (en) Vaccine
GB9915106D0 (en) Vaccine
GB9925618D0 (en) Vaccine
GB9904405D0 (en) Vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase